HMN 2025: How Metabolic community simulations reveal potential gene targets to re-sensitize drug-resistant breast cancer

One of the largest obstacles in cancer therapy is drug resistance in cancer cells. Conventional efforts have centered on figuring out new drug targets to get rid of these resistant cells, however such approaches can typically result in even stronger resistance.

A analysis crew led by Professors Hyun Uk Kim and Yoosik Kim from the Department of Chemical and Biomolecular Engineering developed a computational framework that predicts metabolic gene targets to re-sensitize drug-resistant breast cancer cells. This was achieved utilizing a metabolic community model able to simulating human metabolism.

This method holds promise not just for a wide range of cancer therapies but additionally for treating metabolic ailments reminiscent of diabetes.

The study was published in Proceedings of the National Academy of Sciences.

Focusing on metabolic alterations—key traits within the formation of drug resistance—the researchers developed a metabolism-based strategy to determine gene targets that would improve drug responsiveness by regulating the metabolism of drug-resistant breast cancer cells.

The crew first constructed cell-specific metabolic community models by integrating proteomic knowledge obtained from two several types of drug-resistant MCF7 breast cancer cell strains: one immune to doxorubicin and the opposite to paclitaxel. They then carried out gene knockout simulations on all the metabolic genes and analyzed the outcomes.

As a outcome, they found that suppressing sure genes might make beforehand resistant cancer cells attentive to anticancer medicine once more. Specifically, they recognized GOT1 as a goal in doxorubicin-resistant cells, GPI in paclitaxel-resistant cells, and SLC1A5 as a standard goal for each medicine.

The predictions had been experimentally validated by suppressing proteins encoded by these genes, which led to the re-sensitization of the drug-resistant cancer cells.

Furthermore, constant re-sensitization results had been additionally noticed when the identical proteins had been inhibited in different varieties of breast cancer cells that had developed resistance to the identical medicine.

Professor Yoosik Kim mentioned, “Cellular metabolism performs a vital position in numerous intractable ailments, together with infectious and degenerative situations. This new expertise, which predicts metabolic regulation switches, can function a foundational instrument not just for treating drug-resistant breast cancer but additionally for a variety of ailments that presently lack efficient therapies.”

Professor Hyun Uk Kim, who led the review, emphasised, “The significance of this analysis lies in our capability to precisely predict key metabolic genes that may make resistant cancer cells attentive to therapy once more—utilizing solely pc simulations and minimal experimental knowledge. This framework may be extensively utilized to find new therapeutic targets in numerous cancers and metabolic ailments.”